Peer To Peer Network (OTC: PTOP) Targets Revenue Inflection Point with MOBICARD 1.8 Launch Expected Within 30 Days 
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets 
CEO.CA’s Inside the Boardroom: TAG Oil Has a Pioneering Role in Egypt’s National Energy Push 
Syntheia Announces Resignation of Director 
UberDoc Health Technologies Corp. Announces Board Transition as Jeffrey Hogan Focuses on The Judi Group Ten new products every year: Olainfarm masterplans future gains in Central and Eastern Europe
By investing EUR 100 million over a five year period and developing ten new products…
Announcement by AS “AB CITY” on the offer to purchase AS “Olainfarm” shares
With the following AS “Olainfarm” informs that on September 30, 2021 it has received announcement…
Non-Executive Director Appointment
Synairgen plc(‘Synairgen’ or the ‘Company’) Non-Executive Director Appointment Southampton, UK – 30 September 2021: Synairgen…
Interim results for the six months ended 30 June 2021
Synairgen plc(‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2021…
Algenex enters biocomponents market to provide mammalian-free production of cost efficient high-quality proteins and peptides
PRESS RELEASE Algenex enters biocomponents market to provide mammalian-free production of cost efficient high-quality proteins…
Immunicum Appoints New Experts in Cancer Immunology to Scientific Advisory Board
Press Release 30 September 2021 Immunicum Appoints New Experts in Cancer Immunology to Scientific Advisory…
Basilea’s partner Asahi Kasei Pharma filed New Drug Application for the marketing authorization of isavuconazole in Japan
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, September 30, 2021 Basilea Pharmaceutica…
Novartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions
Reached nearly 29 million patients to date in 2021 through our flagship programs and strategic…
Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load within seven days of treatment in patients hospitalised with COVID-19
Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with…
Interim Results for the Six Months ended 30 June 2021 – Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
OXURION Announces Positive Results from Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME)
Decision taken to move the highest dose of THR-149 (0.13mg) into Part B of the…
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Senior Vice President
HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology…
Tower One Wireless Enters a New Debt Financing Arrangement for US$25,000,000 With Itaú Corpbanca Colombia S.A. and a Local Partner
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021
GAITHERSBURG, Md., Sept. 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
SeqLL Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering
WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL;…
CENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects
Collaborative research utilized insights gained from CENTOGENE’s rare disease-centric Bio/Databank to help analyze data of…
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
SAN DIEGO, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
Coherus BioSciences Mourns the Passing of Board Member Dr. Samuel Nussbaum
REDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — It is with profound sadness that…
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update Financial highlights Cash and…